SR

Sudhakara Reddy Kalakota

Active Director Director DIN 09319680
DIN 09319680 First appointment Jun 2002 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 3 historical roles
Total affiliations 6 Since Jun 2002
Shareholding value •••• Premium profile

About Sudhakara Reddy Kalakota

Data last updated:

Sudhakara Reddy Kalakota has 24 years in corporate governance. Holds Director role. Currently with 3 companies, including Nuvista Pharmaceuticals Private Limited and Plus India Formulation Private Limited. Formerly with 3 companies, such as Beulah Biomedics Private Limited and Proton Remedies Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹13.83 Cr; the largest is Nuvista Pharmaceuticals Private Limited at ₹10.25 Cr (FY 2023).

DIN 09319680
Primary Designation Director
First Appointment 17 Jun 2002
Oldest Company Age 31 yrs
Largest company Nuvista Pharmaceuticals Private Limited · ₹10.25 Cr (FY 2023)
Combined revenue ₹13.83 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Sep 20212017₹10.25 Cr (FY 2023)Active
Director14 Sep 20212021₹3.55 Cr (FY 2025)Active
Krishna Aqua Farms Private Limited U05001OR1994PTC003758
Director20 Nov 20241994₹3.2 Lakh (FY 2017)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Beulah Biomedics Private Limited U24239TG2002PTC039136
Director17 Jun 20022002–Strike Off
Proton Remedies Private Limited U24232TG2008PTC061073
Director17 Sep 20082008₹10.29 Cr (FY 2025)Active
Director02 Feb 20112011₹1.18 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Nuvista Pharmaceuticals Private Limited
Plus India Formulation Private Limited
Krishna Aqua Farms Private Limited
Beulah Biomedics Private Limited
Premium access

Shareholding and investment profile for Sudhakara Reddy Kalakota

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudhakara Reddy Kalakota

Sudhakara Reddy Kalakota has 24 years in corporate governance. Holds Director role. Currently with 3 companies, including Nuvista Pharmaceuticals Private Limited and Plus India Formulation Private Limited. Formerly with 3 companies, such as Beulah Biomedics Private Limited and Proton Remedies Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹13.83 Cr; the largest is Nuvista Pharmaceuticals Private Limited at ₹10.25 Cr (FY 2023).

Sudhakara Reddy Kalakota is associated with 3 companies as Director, including Nuvista Pharmaceuticals Private Limited (₹10.25 Cr), Plus India Formulation Private Limited (₹3.55 Cr), Krishna Aqua Farms Private Limited (₹3.2 Lakh).

Sudhakara Reddy Kalakota has expertise in General Business.

Sudhakara Reddy Kalakota has 24 years in corporate governance.

By reported revenue, the largest current company of Sudhakara Reddy Kalakota is Nuvista Pharmaceuticals Private Limited, with revenue of ₹10.25 Cr (FY 2023).

The 3 current companies of Sudhakara Reddy Kalakota that report revenue have a combined latest revenue of ₹13.83 Cr.

Sudhakara Reddy Kalakota currently holds positions at 3 companies: Nuvista Pharmaceuticals Private Limited (₹10.25 Cr), Plus India Formulation Private Limited (₹3.55 Cr), Krishna Aqua Farms Private Limited (₹3.2 Lakh).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available